BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9271229)

  • 1. Defective cell migration in an ovarian cancer cell line is associated with impaired urokinase-induced tyrosine phosphorylation.
    Mirshahi SS; Lounes KC; Lu H; Pujade-Lauraine E; Mishal Z; Bénard J; Bernadou A; Soria C; Soria J
    FEBS Lett; 1997 Jul; 411(2-3):322-6. PubMed ID: 9271229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
    Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
    Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.
    Reuning U; Bang NU
    Arterioscler Thromb; 1992 Oct; 12(10):1161-70. PubMed ID: 1327097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.
    Carmeliet P; Moons L; Dewerchin M; Rosenberg S; Herbert JM; Lupu F; Collen D
    J Cell Biol; 1998 Jan; 140(1):233-45. PubMed ID: 9425170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogenic effects of urokinase on melanoma cells are independent of high affinity binding to the urokinase receptor.
    Koopman JL; Slomp J; de Bart AC; Quax PH; Verheijen JH
    J Biol Chem; 1998 Dec; 273(50):33267-72. PubMed ID: 9837898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
    Christensen L; Wiborg Simonsen AC; Heegaard CW; Moestrup SK; Andersen JA; Andreasen PA
    Int J Cancer; 1996 May; 66(4):441-52. PubMed ID: 8635858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The urokinase receptor and cell migration.
    Blasi F
    Semin Thromb Hemost; 1996; 22(6):513-6. PubMed ID: 9122717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.
    Guiducci S; Del Rosso A; Cinelli M; Perfetto F; Livi R; Rossi A; Gabrielli A; Giacomelli R; Iori N; Fibbi G; Del Rosso M; Cerinic MM
    Arthritis Res Ther; 2005; 7(6):R1244-53. PubMed ID: 16277677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of the enzymatic and signaling activities of plasmin for phorbol-ester-induced scattering of colon cancer cells.
    Díaz VM; Hurtado M; Kort EJ; Resnati M; Blasi F; Thomson T; Paciucci R
    Exp Cell Res; 2006 Jul; 312(12):2203-13. PubMed ID: 16631161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
    Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator.
    Solberg H; Løber D; Eriksen J; Ploug M; Rønne E; Behrendt N; Danø K; Høyer-Hansen G
    Eur J Biochem; 1992 Apr; 205(2):451-8. PubMed ID: 1374026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of a urokinase receptor-related low-molecular-weight molecule in colorectal adenocarcinomas.
    Lau HK; Kim M; Koo J; Chiu B; Murray D
    Clin Exp Metastasis; 1995 Nov; 13(6):492-8. PubMed ID: 7586807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor.
    Anichini E; Fibbi G; Pucci M; Caldini R; Chevanne M; Del Rosso M
    Exp Cell Res; 1994 Aug; 213(2):438-48. PubMed ID: 8050501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.
    Zheng MH; Fan Y; Panicker A; Smith A; Robertson T; Wysocki S; Robbins P; Papadimitriou JM; Wood DJ
    Am J Pathol; 1995 Dec; 147(6):1559-66. PubMed ID: 7495280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of c-fos gene expression by urokinase-type plasminogen activator in human ovarian cancer cells.
    Dumler I; Petri T; Schleuning WD
    FEBS Lett; 1994 Apr; 343(2):103-6. PubMed ID: 8168613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells.
    Li XN; Varma VK; Parks JM; Benza RL; Koons JC; Grammer JR; Grenett H; Tabengwa EM; Booyse FM
    Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):410-9. PubMed ID: 7749851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor.
    Fibbi G; Pucci M; Grappone C; Pellegrini G; Salzano R; Casini A; Milani S; Del Rosso M
    Hepatology; 1999 Mar; 29(3):868-78. PubMed ID: 10051491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell invasion is affected by differential expression of the urokinase plasminogen activator/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients.
    Fibbi G; Barletta E; Dini G; Del Rosso A; Pucci M; Cerletti M; Del Rosso M
    Lab Invest; 2001 Jan; 81(1):27-39. PubMed ID: 11204271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
    Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
    Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro.
    Wilson AJ; Gibson PR
    Gut; 2000 Jul; 47(1):105-11. PubMed ID: 10861271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.